[go: up one dir, main page]

ES537300A0 - Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion - Google Patents

Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion

Info

Publication number
ES537300A0
ES537300A0 ES537300A ES537300A ES537300A0 ES 537300 A0 ES537300 A0 ES 537300A0 ES 537300 A ES537300 A ES 537300A ES 537300 A ES537300 A ES 537300A ES 537300 A0 ES537300 A0 ES 537300A0
Authority
ES
Spain
Prior art keywords
gangliosides
nebulization
administrable
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537300A
Other languages
English (en)
Other versions
ES8608532A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of ES8608532A1 publication Critical patent/ES8608532A1/es
Publication of ES537300A0 publication Critical patent/ES537300A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES537300A 1983-11-08 1984-10-31 Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion Expired ES8608532A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
ES8608532A1 ES8608532A1 (es) 1986-07-16
ES537300A0 true ES537300A0 (es) 1986-07-16

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537300A Expired ES8608532A1 (es) 1983-11-08 1984-10-31 Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion

Country Status (22)

Country Link
US (1) US4639437A (es)
EP (1) EP0145209B1 (es)
JP (1) JPS60132920A (es)
KR (1) KR850003503A (es)
AT (1) ATE47035T1 (es)
AU (1) AU569920B2 (es)
BE (1) BE900994A (es)
CH (1) CH662278A5 (es)
DE (1) DE3480053D1 (es)
DK (1) DK160129C (es)
ES (1) ES8608532A1 (es)
FR (1) FR2554346B1 (es)
GR (1) GR80853B (es)
IL (1) IL73292A (es)
IN (1) IN163563B (es)
IT (1) IT1212896B (es)
LU (1) LU85633A1 (es)
MX (1) MX163574B (es)
NO (1) NO844443L (es)
NZ (1) NZ209974A (es)
PT (1) PT79466B (es)
ZA (1) ZA848541B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
ATE156704T1 (de) * 1989-12-05 1997-08-15 Ramsey Foundation Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
US6407061B1 (en) * 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
US7842677B2 (en) 2001-08-29 2010-11-30 Seneb Biosciences, Inc. Synthetic ganglioside derivatives and compositions thereof
NZ567841A (en) 2003-03-06 2010-01-29 Seneb Biosciences Inc Methods and compositions for the enzymatic synthesis of gangliosides
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (es) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
JPS60132920A (ja) 1985-07-16
FR2554346A1 (fr) 1985-05-10
US4639437A (en) 1987-01-27
ES8608532A1 (es) 1986-07-16
IL73292A0 (en) 1985-01-31
DK160129B (da) 1991-02-04
BE900994A (nl) 1985-05-07
IL73292A (en) 1988-07-31
DK505584D0 (da) 1984-10-23
EP0145209A2 (en) 1985-06-19
DK505584A (da) 1985-05-09
KR850003503A (ko) 1985-06-20
NO844443L (no) 1985-05-09
PT79466B (en) 1986-12-12
PT79466A (en) 1984-12-01
IT8349288A0 (it) 1983-11-08
DK160129C (da) 1991-07-01
ZA848541B (en) 1985-06-26
ATE47035T1 (de) 1989-10-15
IN163563B (es) 1988-10-08
GR80853B (en) 1985-02-26
AU569920B2 (en) 1988-02-25
CH662278A5 (fr) 1987-09-30
EP0145209B1 (en) 1989-10-11
LU85633A1 (fr) 1985-06-04
FR2554346B1 (fr) 1987-11-20
IT1212896B (it) 1989-11-30
EP0145209A3 (en) 1986-11-26
NZ209974A (en) 1987-02-20
AU3518984A (en) 1985-05-16
DE3480053D1 (en) 1989-11-16
JPH0211570B2 (es) 1990-03-14
MX163574B (es) 1992-06-02

Similar Documents

Publication Publication Date Title
ES537300A0 (es) Procedimiento para la preparacion de gangliosidos y sus derivados administrables por nebulizacion
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
PT98291A (pt) Processo para a preparacao de composicoes farmaceuticas contendo flupirtina para combater distensoes musculares
ES511986A0 (es) "un procedimiento para la preparacion de nuevas 1,2,3,4 tetrahidro 2 naftilaminas".
SE8500996D0 (sv) Method of treatment
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
ES538982A0 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ES532331A0 (es) Procedimiento para preparar derivados de 4-oxo-tiazolidin-2-iliden-acetamida
GR75239B (es)
FI853229L (fi) Nya benzodiazepiner, foerfarande foer deras framstaellning och deras anvaendning.
IL54462A0 (en) Pharmaceutical compositions intended especially for the treatment of functional disorders of the brain, comprising purine derivatives
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.
BR9611913A (pt) Composições contendo bismuto para a prevenção e tratamento de distúrbios gastrintestinais
IT1107843B (it) Composizione terapeutica contenente un alcanolo superiore particolarmente per la cura di disturbi secretori prostatici
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
MX9204908A (es) Composiciones farmaceuticas para el tratamiento de transtornos de la piel.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519